BioWorld

Aug. 23, 2004

Illumina Sale Raises $15M; Applera Legal Dispute Over

Brightening the picture for Illumina Inc. were two pieces of news: the sale of its San Diego facilities for $42 million (with a 10-year lease-back agreement) and the settlement of a court battle with Applera Corp. (BioWorld Today) Read More

Bayer Spins Out Aerovance; Firm Starts With Two Products, $32M

FDA, Crawford Set Agency's Priorities For Next Six Months

Implantable Drug Firm Valera Gets $11.5M In Third Round

Other News To Note

Appointments And Advancements

U.S. Patent Disclosures

Today's news in brief

BioWorld

BioWorld briefs for Dec. 10, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 10, 2025.

Epigenetic technology could eliminate misfolded prion proteins

BioWorld Science

The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

Brenig Therapeutics discovers new LRRK2 inhibitors

BioWorld Science

Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...